BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22797769)

  • 1. Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room?
    Anderson WJ; Lipworth BJ; Rekhraj S; Struthers AD; George J
    Chest; 2013 Jan; 143(1):91-97. PubMed ID: 22797769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Left Ventricular Hypertrophy on In-Hospital Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vallabhajosyula S; Sundaragiri PR; Kanmanthareddy A; Ahmed AA; Mahfood Haddad T; Rayes HA; Khan AN; Buaisha HM; Pershwitz GE; McCann DA; Holmberg MJ; Morrow LE
    COPD; 2016 Dec; 13(6):712-717. PubMed ID: 27379826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease.
    Short PM; Anderson WJ; Elder DH; Struthers AD; Lipworth BJ
    Lung; 2015 Aug; 193(4):487-95. PubMed ID: 25821177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Li ZB; Wachtell K; Okin PM; Gerdts E; Liu JE; Nieminen MS; Jern S; Dahlöf B; Devereux RB
    J Hum Hypertens; 2004 Jun; 18(6):397-402. PubMed ID: 15071485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
    Cuspidi C; Macca G; Sampieri L; Michev I; Fusi V; Salerno M; Severgnini B; Corti C; Magrini F; Zanchetti A
    J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis.
    Orlowska-Baranowska E; Baranowski R; Greszata L; Stepinska J
    J Heart Valve Dis; 2008 Nov; 17(6):598-605. PubMed ID: 19137789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
    Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography.
    Barbieri A; Bursi F; Mantovani F; Valenti C; Quaglia M; Berti E; Marino M; Modena MG
    Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):109-17. PubMed ID: 21979990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study.
    Gerdts E; Okin PM; Omvik P; Wachtell K; Dahlöf B; Hildebrandt P; Nieminen MS; Devereux RB
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):306-12. PubMed ID: 19303268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients.
    Usui Y; Tomiyama H; Hashimoto H; Takata Y; Inoue Y; Asano K; Kurohane S; Shiina K; Hirayama Y; Yamashina A
    J Hypertens; 2008 Jan; 26(1):117-23. PubMed ID: 18090548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients.
    Huang YS; Feng YC; Zhang J; Bai L; Huang W; Li M; Sun Y
    Clin Interv Aging; 2015; 10():81-7. PubMed ID: 25565790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
    Seo HY; Lee SP; Park JB; Lee JM; Park EA; Chang SA; Kim HK; Park SJ; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Choe YH
    J Am Soc Echocardiogr; 2015 Oct; 28(10):1194-1203, e2. PubMed ID: 26194306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of midwall systolic function in left ventricular hypertrophy: a comparison of 3-dimensional versus 2-dimensional echocardiographic indices.
    Jung HO; Sheehan FH; Bolson EL; Waiss MP; Otto CM
    J Am Soc Echocardiogr; 2006 Jun; 19(6):802-10. PubMed ID: 16762760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide levels in middle aged subjects with normal left ventricular function in relation to mild-moderate COPD.
    Kraen M; Frantz S; Nihlén U; Engström G; Löfdahl CG; Wollmer P; Dencker M
    Clin Respir J; 2018 Mar; 12(3):1061-1067. PubMed ID: 28294547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.